Previous studies on severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) have shown temporary increases in specific antibodies, and that antibody levels decline quickly in patients after recovery, whereas the specific CD4+ and CD8+ T-cell responses play an essential role in the control of SARS and MERS (17, 18). The gene discussed is CD4; the disease is severe acute respiratory syndrome.